This transdifferentiation can be activated by hyperphosphatemia, hypercalcemia, hyperglycemia, and inflammation [43], and involves with various osteogenic transcription factors, including core binding factor alpha-1(CBFA1), msh homeobox 2 (MSX2), and osterix (Osx). Here, SP7 is linked to hypercalcemia disease.